Financials (USD)
Sales 2023 * | 25.98M | Sales 2024 * | 34.54M | Capitalization | 246M |
---|---|---|---|---|---|
Net income 2023 * | -43M | Net income 2024 * | -51M | EV / Sales 2023 * | 8.07 x |
Net cash position 2023 * | 36.8M | Net Debt 2024 * | 3.3M | EV / Sales 2024 * | 7.23 x |
P/E ratio 2023 * |
-5.02
x | P/E ratio 2024 * |
-4.68
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 88.61% |
Latest transcript on KemPharm, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Christal Mickle
FOU | Founder | 44 | 06-10-29 |
Neil McFarlane
CEO | Chief Executive Officer | 52 | 23-10-09 |
R. Clifton
DFI | Director of Finance/CFO | 51 | 15-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wendy Dixon
BRD | Director/Board Member | 68 | 23-04-24 |
David Tierney
BRD | Director/Board Member | 60 | 15-03-09 |
Tamara Favorito
CHM | Chairman | 65 | 21-08-17 |
1st Jan change | Capi. | |
---|---|---|
+14.56% | 9.82B | |
-7.87% | 5.49B | |
+12.50% | 4.21B | |
+18.09% | 3.66B | |
+44.47% | 2.93B | |
-19.01% | 2.54B | |
-20.66% | 2.35B | |
+16.86% | 1.85B | |
-0.50% | 1.64B |